Journal: Clinical pharmacology and therapeutics
Article Title: Multi-site investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy
doi: 10.1002/cpt.1006
Figure Lengend Snippet: Pharmacogenomic testing
Article Snippet: Median genotype turnaround time (TAT), defined as each institution’s median time from genotype order to result appearing in the EHR, varied widely among institutions, from very short (1 to 5 hours with rapid testing platforms such as Spartan RX), to 1-3 days with standard single-gene test platforms in reactive models (GenMark eSensor XT-8 or custom Taqman® assays), to longer (6 to 8 days) for those institutions who used preemptive panel-based or send-out testing strategies.
Techniques: TaqMan Assay